2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol | 138958-70-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol
• 英文别名: 2-Methoxy-5-[(3,4,5-trimethoxyphenyl)methyl]phenol
• CAS: 138958-70-0
• 化学式: C₁₇H₂₀O₅
• 分子量: 304.343
• InChiKey: JFZDWXGLUXEEAY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1-溴-3,4,5-三甲氧基苯 在 正丁基锂 、 四丁基氟化铵 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 3.5h， 生成 2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol
  参考文献：
  名称：

  毛兰素类似物作为肝癌细胞丙酮酸羧化酶抑制剂的设计、合成及构效关系研究

  摘要：

  基于生物等排原理，通过改变毛兰素的两个芳香环、环上的取代基以及环上的连接基，设计合成了一系列新型毛兰素类似物。该类似物在肝细胞癌细胞中作为丙酮酸羧化酶 (PC) 抑制剂进行了评估。结果发现，用氟取代羟基的化合物35和36在肝癌细胞中表现出比毛兰素更高的活性（IC 50值为17.30 nM），IC 50值分别为15.15 nM和10.05 nM。此外，在10 nM浓度下，化合物35和36对PC的抑制率分别为39.10%和40.15%，表现出与毛兰素几乎相同的抑制活性（抑制率为40.07%）。此外，计算机模拟对接研究证明了受体和配体之间更好相互作用的基础。35的氟原子不仅可以与Lys-1043（NH⋯F，2.04 Å）形成氢键，还可以与Lys-1043（3.67 Å）和Glu-1046（3.70 Å）的羰基形成氟键，由于B环弹头上的卤素的取向不同。相反， 34的氯原子只能与Lys-1043中的

  DOI：

  10.1039/d3ob01114c

文献信息

• 毛兰素类似物及其合成方法和应用
  申请人：中国科学院成都生物研究所

  公开号：CN116535304A

  公开（公告）日：2023-08-04

  本发明属于化合物合成领域，具体涉及毛兰素类似物及其合成方法和应用。具体技术方案为：一类毛兰素类似物，通过特定的连接子链接两个不同的芳香环、多氢芳环或芳香杂环片段形成的化合物，或其构象异构体、旋光异构体或其盐：所述毛兰素类似物为盐时，为所述结构式与矿物酸或有机酸形成的盐。本发明构建这类新的毛兰素类似物的制备方法操作简单、产率高。新构建的毛兰素类似物具有良好的抗癌活性，且半衰期最长为毛兰素的12余倍，具有良好的制药潜力。
• Synthesis of alkoxy-substituted diaryl compounds and correlation of ring separation with inhibition of tubulin polymerization: differential enhancement of inhibitory effects under suboptimal polymerization reaction conditions
  作者：Zelleka Getahun、Leonard Jurd、Ping S. Chu、Chii M. Lin、Ernest Hamel

  DOI：10.1021/jm00084a011

  日期：1992.3

  A number of cytostatic compounds (2-4, 7, and 8), which can be described as ''diaryl'', inhibit tubulin polymerization, cause cells to accumulate in mitotic arrest, and competitively inhibit the binding of colchicine to tubulin. They differ, however, in the separation of the two aryl moieties. To attempt to understand this variability we prepared a series of analogues modeled on 3 and 4 (''benzodioxole series'') and on 7 and 8 (''combretastatin series'') which differed only in the number of methylene units (ranging from none to four) separating the aryl moieties. These compounds were evaluated for their effects on tubulin polymerization, colchicine binding, and the growth of L1210 murine leukemia cells. In terms of inhibitory effects on tubulin polymerization, for the combretastatin series there was an optimal separation of the two phenyl rings by a two-carbon bridge (compound 24), with progressively decreasing inhibitory activity when the separation was by one carbon (20), three carbons (25), or four carbons (28) (the biphenyl analogue 16 was inactive). The benzodioxole series, however, did not permit us to generalize this finding, because the least active agents prepared (39 and 40) had a two-carbon bridge, while those with one- (5 and 6) and three-carbon (46 and 47) bridges were nearly equivalent in potency. Submicromolar IC50 values for inhibition of L1210 cell growth were only obtained for compounds 20 (IC50, 0.2-mu-M), 24 (0.07-mu-M), and 25 (0.4-mu-M). While evaluating the effects of these agents on tubulin polymerization, we noted with the combretastatin series and with several standard agents that apparent potency (in terms of IC50 values) was always lower if the reaction was performed at 30-degrees-C, with 0.25 mM MgCl2, than at 37-degrees-C, with 1.0 mM MgCl2. This enhancement of IC50 values in the former system as compared with the latter was particularly dramatic for the less active agents (e.g., 28) as compared with the more active (e.g. 24).
• Design, synthesis and structure–activity relationship studies on erianin analogues as pyruvate carboxylase inhibitors in hepatocellular carcinoma cells
  作者：Hailong Shi、Jinlian Yang、Zeen Qiao、Lingyu Li、Gang Liu、Qi Dai、Li Xu、Wei Jiao、Guolin Zhang、Fei Wang、Xiaoxia Lu、Xiaofeng Ma

  DOI：10.1039/d3ob01114c

  日期：——

  nM) in liver cancer cells with IC50 values of 15.15 nM and 10.05 nM, respectively. Additionally, at a concentration of 10 nM, compounds 35 and 36 inhibited PC with inhibitory rates of 39.10% and 40.15%, respectively, exhibiting nearly identical inhibitory activity to erianin (inhibitory rate of 40.07%). Additionally, a computer simulation docking study demonstrated the basis for better interactions

  基于生物等排原理，通过改变毛兰素的两个芳香环、环上的取代基以及环上的连接基，设计合成了一系列新型毛兰素类似物。该类似物在肝细胞癌细胞中作为丙酮酸羧化酶 (PC) 抑制剂进行了评估。结果发现，用氟取代羟基的化合物35和36在肝癌细胞中表现出比毛兰素更高的活性（IC 50值为17.30 nM），IC 50值分别为15.15 nM和10.05 nM。此外，在10 nM浓度下，化合物35和36对PC的抑制率分别为39.10%和40.15%，表现出与毛兰素几乎相同的抑制活性（抑制率为40.07%）。此外，计算机模拟对接研究证明了受体和配体之间更好相互作用的基础。35的氟原子不仅可以与Lys-1043（NH⋯F，2.04 Å）形成氢键，还可以与Lys-1043（3.67 Å）和Glu-1046（3.70 Å）的羰基形成氟键，由于B环弹头上的卤素的取向不同。相反， 34的氯原子只能与Lys-1043中的